/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The diagnostics firm was acquired at great cost, but is unable to support PharmEasy’s core online pharmacy business.
Just a few months ago, it looked like PharmEasy was well on the way to listing on the public markets at a valuation of over $5 billion.
But with investors fast losing their appetite for technology stocks in recent months, the online drugs and medical services startup shelved its IPO in November. Now, some of the decisions it took in the run-up to the withdrawn public offer are beginning to bite. In particular, its acquisition of diagnostics chain Thyrocare in June 2021, which has become a millstone around its neck, threatening to thwart PharmEasy’s ambition to build India’s biggest …
The instant house help business has become the centre of focus and investment at the home services company. But another fight may be brewing in its core business.
India’s grocery and food delivery platforms are increasingly displaying misleading images of food using artificial intelligence, defeating the very purpose of buying online.
Parent AceVector is headed for a public market debut next week. As much as 97% of its revenue comes from two businesses. One is already a listed entity, the other a missed opportunity.
